BioNTech (BNTX) operating margin

Operating margin · fiscal 2025
-22.3%

BioNTech (BNTX) had an operating margin of -22.3% in fiscal 2025 (the year ended December 31, 2025). That is 3.5 percentage points higher than the -25.8% of fiscal 2024. Figures as of 17 Nov 2026, 23:17 UTC, from Yahoo Finance.

Key facts

Operating margin, fiscal 2025
-22.3%
Change on fiscal 2024
+3.5 pts
Highest on record
71.1%fiscal 2022
Lowest on record
-25.8%fiscal 2024
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Figures, not advice.

BioNTech operating margin, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was 71.1% in fiscal 2022 and the lowest -25.8% in fiscal 2024. The fiscal 2025 figure is higher than in 33% of the 3 earlier fiscal years on record, whose median is 22.9%.

Gross margin was 77.6% in fiscal 2025. Net margin was -39.6% in fiscal 2025.

History · 4 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Gross margin
  • Net margin

BioNTech operating margin, year by year

BioNTech (BNTX) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedGross marginNet margin
2025-22.3% 3.5 pts up77.6%-39.6%
2024-25.8% 48.7 pts down80.3%-24.2%
202322.9% 48.1 pts down84.3%24.4%
202271.1%—82.7%54.5%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

Operating margin at health care companies of similar size

Operating margin of BioNTech and comparable companies
CompanyOperating marginFiscal year
Viatris VTRS1.8%2025
Tenet Healthcare THC16.1%2025
BioNTech BNTX-22.3%2025
Guardant Health GH-44.5%2025
Alnylam Pharmaceuticals ALNY13.5%2025
Zimmer Biomet Holdings ZBH16.5%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BNTX

BioNTech, figure by figure

BioNTech (BNTX) overview: price, valuation and scorecardAll health care companies by market value

BioNTech operating margin: questions and answers

What is BioNTech's operating margin?

BioNTech (BNTX) had an operating margin of -22.3% in fiscal 2025 (the year ended December 31, 2025). That is 3.5 percentage points higher than the -25.8% of fiscal 2024.

Is BioNTech's operating margin high or low compared with its own history?

The fiscal 2025 figure is higher than in 33% of the 3 earlier fiscal years on record, whose median is 22.9%.

What are the highest and lowest operating margin figures on record for BioNTech?

Across the 4 fiscal years on record (2022–2025), the highest was 71.1% in fiscal 2022 and the lowest -25.8% in fiscal 2024.

What are BioNTech's gross and net margins?

Gross margin was 77.6% in fiscal 2025. Net margin was -39.6% in fiscal 2025.

How is BioNTech's operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “BioNTech (BNTX) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/BNTX/operating-margin

Underlying data: Yahoo Finance.